IL-17A-producing T cells are associated with the progression of lung adenocarcinoma

Oncology Reports

Volumn 36, Issue 2, 2016, Pages 641-650

  Bao, Zhang ^a   Lu, Guohua ^a   Cui, Dawei ^a   Yao, Yinan ^a   Yang, Guangdie ^a   Zhou, Jianying ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

IL 17A; IL 17A producing T cells; IL 23; Lung adenocarcinoma; Lung cancer; Tc17 cells; Th17 cells; T17 cells

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; IL17A PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; GAMMA DELTA TH17 CELL; HELPER CELL; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG SURGERY; LYMPHOCYTE COUNT; MALE; METASTASIS; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; T LYMPHOCYTE; TC17 CELL; TH17 CELL; TUMOR INVASION; ADENOCARCINOMA; DISEASE COURSE; LUNG TUMOR; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; MALE; MIDDLE AGED; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84976504125     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.4837     Document Type: Article

References (61)

1. Islami F, Torre LA and Jemal A: Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res 4: 327-338, 2015.
2. Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin 66: 7-30, 2016.
3. She J, Yang P, Hong Q and Bai C: Lung cancer in China: Challenges and interventions. Chest 143: 1117-1126, 2013.
4. Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell 144: 646-674, 2011.
5. Balkwill F and Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 357: 539-545, 2001.
6. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C and Flavell RA: Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13: 759-771, 2013.
7. Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell 140: 883-899, 2010.
8. Dvorak HF: Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
9. Pálmai-Pallag T and Bachrati CZ: Inflammation-induced DNA damage and damage-induced inflammation: A vicious cycle. Microbes Infect 16: 822-832, 2014.
10. Xu S and Cao X: Interleukin-17 and its expanding biological functions. Cell Mol Immunol 7: 164-174, 2010.
11. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI and Spriggs MK: Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3: 811-821, 1995.
12. Rouvier E, Luciani MF, Mattéi MG, Denizot F and Golstein P: CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 150: 5445-5456, 1993.
13. Iwakura Y, Ishigame H, Saijo S and Nakae S: Functional specialization of interleukin-17 family members. Immunity 34: 149-162, 2011.
14. Cua DJ and Tato CM: Innate IL-17-producing cells: The sentinels of the immune system. Nat Rev Immunol 10: 479-489, 2010.
15. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ and Gurney AL: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278: 1910-1914, 2003.
16. Zhong F, Cui D, Tao H, Du H and Xing C: IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer. Oncol Rep 34: 2365-2374, 2015.
17. Ma S, Cheng Q, Cai Y, Gong H, Wu Y, Yu X, Shi L, Wu D, Dong C and Liu H: IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res 74: 1969-1982, 2014.
18. Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJ, Ciampricotti M, Hawinkels LJ, Jonkers J, et al: IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522: 345-348, 2015.
19. Zhang Q, Liu S, Ge D, Zhang Q, Xue Y, Xiong Z, Abdel-Mageed AB, Myers L, Hill SM, Rowan BG, et al: Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models. Cancer Res 72: 2589-2599, 2012.
20. Silva-Santos B, Serre K and Norell H: γδ T cells in cancer. Nat Rev Immunol 15: 683-691, 2015.
21. Patil RS, Bhat SA, Dar AA and Chiplunkar SV: The Jekyll and Hyde story of IL17-producing γδT cells. Front Immunol 6: 37, 2015.
22. Wang K and Karin M: The IL-23 to IL-17 cascade inflammation-related cancers. Clin Exp Rheumatol 33 (Suppl 92): S87-S90, 2015.
23. Shalapour S and Karin M: Immunity, inflammation, and cancer: An eternal fight between good and evil. J Clin Invest 125: 3347-3355, 2015.
24. Hemdan NY: Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells. Immunol Lett 149: 123-133, 2013.
25. Kryczek I, Wei S, Szeliga W, Vatan L and Zou W: Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114: 357-359, 2009.
26. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, Hwu P, Restifo NP, Overwijk WW and Dong C: T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31: 787-798, 2009.
27. Xu B, Guenther JF, Pociask DA, Wang Y, Kolls JK, You Z, Chandrasekar B, Shan B, Sullivan DE and Morris GF: Promotion of lung tumor growth by interleukin-17. Am J Physiol Lung Cell Mol Physiol 307: L497-L508, 2014.
28. Chang SH, Mirabolfathinejad SG, Katta H, Cumpian AM, Gong L, Caetano MS, Moghaddam SJ and Dong C: T helper 17 cells play a critical pathogenic role in lung cancer. Proc Natl Acad Sci USA 111: 5664-5669, 2014.
29. Chen X, Wan J, Liu J, Xie W, Diao X, Xu J, Zhu B and Chen Z: Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 69: 348-354, 2010.
30. Yang G, Li H, Yao Y, Xu F, Bao Z and Zhou J: Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis. Oncol Rep 33: 478-484, 2015.
31. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L; International Association for the Study of Lung Cancer International Staging Committee, et al: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2: 706-714, 2007.
32. Muranski P and Restifo NP: Essentials of Th17 cell commitment and plasticity. Blood 121: 2402-2414, 2013.
33. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132, 2005.
34. Ye J, Livergood RS and Peng G: The role and regulation of human Th17 cells in tumor immunity. Am J Pathol 182: 10-20, 2013.
35. Guéry L and Hugues S: Th17 Cell plasticity and functions in cancer Immunity. Biomed Res Int 2015: 314620, 2015.
36. Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, Wu C, Li SP and Zheng L: Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50: 980-989, 2009.
37. Li Q, Li Q, Chen J, Liu Y, Zhao X, Tan B, Ai J, Zhang Z, Song J and Shan B: Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters. Oncol Rep 30: 1215-1222, 2013.
38. Chen WC, Lai YH, Chen HY, Guo HR, Su IJ and Chen HH: Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor. Histopathology 63: 225-233, 2013.
39. Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF and Peng G: Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184: 1630-1641, 2010.
40. Shan M, Yuan X, Song LZ, Roberts L, Zarinkamar N, Seryshev A, Zhang Y, Hilsenbeck S, Chang SH, Dong C, et al: Cigarette smoke induction of osteopontin (SPP1) mediates TH17 inflammation in human and experimental emphysema. Sci Transl Med 4: 117ra9, 2012.
41. Ye ZJ, Zhou Q, Gu YY, Qin SM, Ma WL, Xin JB, Tao XN and Shi HZ: Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol 185: 6348-6354, 2010.
42. Li S, Li Y, Qu X, Liu X and Liang J: Detection and significance of TregFoxP3+ and Th17 cells in peripheral blood of non-small cell lung cancer patients. Arch Med Sci 10: 232-239, 2014.
43. Liang Y, Pan HF and Ye DQ: Tc17 cells in immunity and systemic autoimmunity. Int Rev Immunol 34: 318-331, 2015.
44. Kondo T, Takata H, Matsuki F and Takiguchi M: Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J Immunol 182: 1794-1798, 2009.
45. Kuang DM, Peng C, Zhao Q, Wu Y, Zhu LY, Wang J, Yin XY, Li L and Zheng L: Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J Immunol 185: 1544-1549, 2010.
46. Zhang Y, Hou F, Liu X, Ma D, Zhang Y, Kong B and Cui B: Tc17 cells in patients with uterine cervical cancer. PLoS One 9: e86812, 2014.
47. Yu Y, Cho HI, Wang D, Kaosaard K, Anasetti C, Celis E and Yu XZ: Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms. J Immunol 190: 1873-1881, 2013.
48. Garcia-Hernandez ML, Hamada H, Reome JB, Misra SK, Tighe MP and Dutton RW: Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice. J Immunol 184: 4215-4227, 2010.
49. Nelson MH, Kundimi S, Bowers JS, Rogers CE, Huff LW, Schwartz KM, Thyagarajan K, Little EC, Mehrotra S, Cole DJ, et al: The inducible costimulator augments Tc17 cell responses to self and tumor tissue. J Immunol 194: 1737-1747, 2015.
50. Banat GA, Tretyn A, Pullamsetti SS, Wilhelm J, Weigert A, Olesch C, Ebel K, Stiewe T, Grimminger F, Seeger W, et al: Immune and inflammatory cell composition of human lung cancer stroma. PLoS One 10: e0139073, 2015.
51. Jiang G, Ma S, Wei Y, Wu Y, Yu X and Liu H: The prevalence and distribution of Th17 and Tc17 cells in patients with thyroid tumor. Immunol Lett 162: 68-73, 2014.
52. Vantourout P and Hayday A: Six-of-The-best: Unique contributions of γδ T cells to immunology. Nat Rev Immunol 13: 88-100, 2013.
53. Rei M, Pennington DJ and Silva-Santos B: The emerging protumor role of γδ T lymphocytes: Implications for cancer immunotherapy. Cancer Res 75: 798-802, 2015.
54. Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, Wang Z, Wang C, Zhang Z, Xia W, et al: γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 40: 785-800, 2014.
55. Rei M, Gonçalves-Sousa N, Lança T, Thompson RG, Mensurado S, Balkwill FR, Kulbe H, Pennington DJ and Silva-Santos B: Murine CD27-Vγ6+ γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc Natl Acad Sci USA 111: E3562-E3570, 2014.
56. Bystrom J, Taher TE, Muhyaddin MS, Clanchy FI, Mangat P, Jawad AS, Williams RO and Mageed RA: Harnessing the therapeutic potential of Th17 cells. Mediators Inflamm 2015: 205156, 2015.
57. Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA and Oft M: IL-23 promotes tumour incidence and growth. Nature 442: 461-465, 2006.
58. He D, Li H, Yusuf N, Elmets CA, Li J, Mountz JD and Xu H: IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloidderived suppressor cells. J Immunol 184: 2281-2288, 2010.
59. Chung AS, Wu X, Zhuang G, Ngu H, Kasman I, Zhang J, Vernes JM, Jiang Z, Meng YG, Peale FV, et al: An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med 19: 1114-1123, 2013.
60. Yang B, Kang H, Fung A, Zhao H, Wang T and Ma D: The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. Mediators Inflamm 2014: 623759, 2014.
61. Lo Re S, Dumoutier L, Couillin I, Van Vyve C, Yakoub Y, Uwambayinema F, Marien B, van den Brûle S, Van Snick J, Uyttenhove C, et al: IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol 184: 6367-6377, 2010.